Cargando…
EVALUATION OF THROMBOEMBOLIC EVENTS AND ANTICOAGULANT STRATEGIES IN PATIENTS WITH COVID-19: A RETROSPECTIVE ANALYSIS
Autores principales: | LYN DELA CRUZ, JESSEL, MALESKER, MARK, PLAMBECK, ROBERT, DESTACHE, CHRIS, SHAFER, DWIGHT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503435/ http://dx.doi.org/10.1016/j.chest.2021.07.1024 |
Ejemplares similares
-
Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016) -
Emergency Reversal of Anticoagulation
por: Yee, Jennifer, et al.
Publicado: (2019) -
ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021) -
HIGH THROMBUS BURDEN IN A PATIENT WITH COVID-19 ON ANTICOAGULATION
por: LATEF, T., et al.
Publicado: (2022) -
Respone to: “Limitations of Retrospective Chart Reviews to Determine Rare Events, and the Unknown Relative Risk of Droperidol”
por: Cole, Jon B., et al.
Publicado: (2021)